News Releases

News Releases

Date Title and Summary Additional Formats
Toggle Summary Galera Therapeutics Raises $11 Million in Series A Financing
Funding to Support Clinical Development of Therapeutics for Fibrosis and Cancer Galera Names Mel Sorensen, M.D. New President and CEO; Robert Beardsley, Ph.D., Executive Chair MALVERN, Pa. and ST. LOUIS , Mo. –  December 11, 2012  –  Galera Therapeutics, Inc., a biotechnology company focused on the
View HTML